The pain neuropharmacology research group of the ibs.GRANADA receives two prestigious awards

Two articles published by the research group B-28 of Neuropharmacology of pain of the ibs.GRANADA They have received two very important awards this week.

The first work was published in the journal PNAS, and in it the researchers succeeded in making white blood cells relieve pain, instead of producing it, during tissue inflammation in mice (see the news published by the Office of Communication Management : (https://goo.gl/jcPt9V).

This work, led by scientists from Granada (belonging to the Department of Pharmacology and the Institute of Neurosciences of the Center for Biomedical Research, and the Biosanitary Research Institute of Granada), together with the Esteve pharmaceutical company, the Medicamento, and the Austrian Institute of Molecular Biotechnology, has received the award from the Royal Academy of Medicine and Surgery of Eastern Andalusia (RAMAO).

The award ceremony will be this Saturday, January 26, at 12 noon at the RAMAO headquarters.

The second award-winning article has been published in the journal Cell Reports, and it is a genetic study that opens the doors to the development of analgesics against neuropathic pain, one of the most disabling pathologies that exist (https://goo.gl/ JzaVQq).

This work, carried out jointly by the University of Granada, Harvard, University of California and Los Angeles (UCLA), Université Laval and The Jackson Laboratory, has been awarded by the Grünenthal Foundation for Research in Pain 2018, convened in collaboration with the Chair Grünenthal Foundation Extraordinary Pain of the University of Salamanca, in the Basic Research category.

The award ceremony will be on January 28 in Salamanca during the celebration of the feast of Santo Tomás de Aquino.